GlassScriptPhysician profile
Heather D Hokanson
NPI 1417109844
$5,241.41
in general payments reported to CMS, 2019-2025
40 companies · $1,736 in 2025
The $1,736 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.90 · 2022: $445 · 2023: $1,463 · 2024: $1,513 · 2025: $1,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,628 · Education: $85.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,627.54 |
| Education | $85.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,079.77 | 2022-2025 | |
| Novo Nordisk INC | $536.85 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $464.71 | 2022-2025 | |
| Lilly USA, LLC | $376.25 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $329.32 | 2023-2025 | Breztri, Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $290.44 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Corcept Therapeutics | $216.15 | 2023-2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $211.75 | 2025 | Voquezna |
| Myriad Women'S Health, INC. | $159.21 | 2023 | Myrisk |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.52 | 2021-2023 | Tradjenta, Jardiance |
| Shield Therapeutics INC | $141.10 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $127.34 | 2023-2025 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.57 | 2024-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $89.21 | 2023-2024 | Freestyle Libre 3 |
| Corium, LLC | $87.88 | 2022-2023 | Azstarys |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hokanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.